Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Perronne

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 25, 2020
Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240]Jérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Annals of Internal Medicine|October 16, 2002
Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapyLouis Bernard, Albert Vuagnat, Gilles Peytavin, et al.
Plos One|October 21, 2014
Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West AfricaChristine Danel, Mathieu Kabran, André Inwoley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyFirouzé Bani-Sadr, Fabrice Carrat, Stanislas Pol, et al.
International Journal of Antimicrobial Agents|August 7, 2020
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over timeBenjamin Davido, Ghilas Boussaid, Isabelle Vaugier, et al.
JAMA|December 16, 2004
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trialFabrice Carrat, Firouzé Bani-Sadr, Stanislas Pol, et al.
Journal of Medical Genetics|February 13, 2007
A novel X-linked recessive form of Mendelian susceptibility to mycobaterial diseaseJacinta Bustamante, Capucine Picard, Claire Fieschi, et al.
The Lancet. Infectious Diseases|April 28, 2009
Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious DiseasePhilippe Brouqui, Vincenzo Puro, Francesco M Fusco, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countriesGiuseppina De Iaco, Vincenzo Puro, Francesco Maria Fusco, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 25, 2020
Retraction notice to "Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial." [PHYTOMEDICINE 51C (2018) 233-240]Jérôme Munyangi, Lucile Cornet-Vernet, Michel Idumbo, et al.
Annals of Internal Medicine|October 16, 2002
Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapyLouis Bernard, Albert Vuagnat, Gilles Peytavin, et al.
Plos One|October 21, 2014
Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West AfricaChristine Danel, Mathieu Kabran, André Inwoley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2005
Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapyFirouzé Bani-Sadr, Fabrice Carrat, Stanislas Pol, et al.
International Journal of Antimicrobial Agents|August 7, 2020
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over timeBenjamin Davido, Ghilas Boussaid, Isabelle Vaugier, et al.
JAMA|December 16, 2004
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trialFabrice Carrat, Firouzé Bani-Sadr, Stanislas Pol, et al.
Journal of Medical Genetics|February 13, 2007
A novel X-linked recessive form of Mendelian susceptibility to mycobaterial diseaseJacinta Bustamante, Capucine Picard, Claire Fieschi, et al.
The Lancet. Infectious Diseases|April 28, 2009
Infection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious DiseasePhilippe Brouqui, Vincenzo Puro, Francesco M Fusco, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countriesGiuseppina De Iaco, Vincenzo Puro, Francesco Maria Fusco, et al.
Trials|May 22, 2012
A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) projectCorinne S C Merle, Charalambos Sismanidis, Oumou Bah Sow, et al.
Pageof 10